Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Indexed in the following public directories
Overview | |
Publisher | SAGE PUBLICATIONS LTD |
Language | English |
Frequency | Continuous publication |
Article Processing Charges | USD 2300 |
Publication Time | 10 |
Editorial Review Process | Anonymous peer review |
General Details | |
Language | English |
Society/Institute/Sponsor | British Association for Psychopharmacology |
Frequency | Continuous publication |
Publication Start Year | 2011 |
Publisher URL | Visit website |
Website URL | Visit website |
Publication Details | |
Plagiarism | Visit website |
Waiver Policy | Visit website |
Publication Time | 10 |
Article Processing Charges | USD 2300 |
Editorial Review Detail | |
Editorial Team | Visit website |
Review Process | Anonymous peer review |
Review Url | Visit website |
Information for authors | |
Author instructions | Visit website |
Copyright Details | Visit website |
Deposit Policy | Sherpa/Romeo |
License type | CC BY, CC BY-NC |
OA statement | Visit website |
Upload your Manuscript to get
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my Paper540 articles received 8.8k citations see all
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY has been in operation since 2011 till date.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY published with a Continuous publication frequency.
In 2023, THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY published 35 articles.
For THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY,eISSN is 2045-1261 and pISSN is2045-1253.
SAGE PUBLICATIONS LTD is the publisher of THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY.